IFNAR2 and hepatocellular carcinoma: The present study revealed that, in addition to the significant association between IGFBP7 status and the clinical response to IFN-α/5-FU therapy, the IGFBP7 status as well as IFNAR2, was an independent prognostic factor in HCC patients undergoing IFN-α/5-FU therapy.